CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.

Autor: Gabr H; Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., El Ghamrawy MK; Pediatric, Faculty of Medicine, Cairo University, Cairo, Egypt., Almaeen AH; Pathology Department, Jouf University, Sakakah, Saudi Arabia., Abdelhafiz AS; Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt., Hassan AOS; Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., El Sissy MH; Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. mahaelsissy@yahoo.com.

Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2020 Sep 10; Vol. 11 (1), pp. 390. Date of Electronic Publication: 2020 Sep 10.